Wormwood does interact with several categories of medications, and some of these interactions are serious. The most well-documented risks involve blood thinners, diabetes drugs, and sedatives. Wormwood also affects liver enzymes responsible for breaking down a wide range of common medications, which means the list of potential interactions extends well beyond these three categories.
How Wormwood Affects Drug Metabolism
Your liver uses a family of enzymes to process and clear medications from your body. Two of the most important, CYP2B6 and CYP3A4, are significantly inhibited by Artemisia plant extracts. In laboratory studies using human liver tissue, wormwood-related extracts reduced CYP2B6 activity by nearly 89% and CYP3A4 activity by about 71%. What makes this particularly concerning is that the inhibition is irreversible. The plant’s compounds form permanent bonds with the enzyme, destroying its function rather than temporarily blocking it. The body has to manufacture entirely new enzymes to restore normal drug processing.
CYP3A4 alone is responsible for metabolizing roughly half of all prescription drugs. When this enzyme is knocked out, medications that would normally be cleared from your system at a predictable rate instead build up to higher, potentially dangerous concentrations. This is the same basic mechanism behind the well-known grapefruit-drug interaction, but the irreversible nature of wormwood’s effect makes it potentially longer-lasting.
Blood Thinners: A Documented Danger
The most alarming interaction on record involves warfarin. In one published case, an 82-year-old woman taking warfarin for atrial fibrillation was hospitalized with gastrointestinal bleeding after consuming wormwood. Her INR (a measure of how thin the blood is) had risen to extremely elevated levels. A standardized assessment rated the connection between wormwood use and the bleeding event as “probable.”
Warfarin has what pharmacologists call a narrow therapeutic index, meaning the difference between an effective dose and a dangerous one is small. Any substance that slows warfarin’s breakdown in the liver, as wormwood’s enzyme inhibition would do, can push blood levels into a range where spontaneous bleeding becomes likely. If you take warfarin or other blood-thinning medications, wormwood poses a clear and serious risk.
Diabetes Medications
Wormwood species have blood sugar-lowering properties on their own, which creates the potential for additive effects when combined with diabetes drugs. In a study on diabetic rats, combining an Artemisia extract with glyburide (a common oral diabetes medication) produced significantly greater reductions in fasting blood glucose and improvements in insulin levels compared to glyburide alone. The combination normalized blood sugar in a way that neither treatment achieved on its own.
Interestingly, the researchers in that particular study did not observe an increased risk of hypoglycemia with the combination. But this was a controlled animal study with specific dosing. In real-world use, where wormwood supplement potency varies widely and people take different diabetes medications at different doses, the risk of blood sugar dropping too low is a genuine concern. If you use insulin or oral medications to manage diabetes, adding wormwood could unpredictably amplify their effects.
Sedatives and Anti-Anxiety Drugs
Wormwood has measurable sedative properties that appear to work through the same brain receptors targeted by benzodiazepines like diazepam and lorazepam. In mouse studies, wormwood extracts increased sedation in a dose-dependent manner, and this effect was reversed by flumazenil, which is the standard antidote for benzodiazepine overdose. The fact that flumazenil blocks wormwood’s sedative effect strongly suggests both substances act on the same receptor system.
This means combining wormwood with benzodiazepines, sleep medications, or other central nervous system depressants could produce excessive drowsiness, slowed breathing, or dangerously deep sedation. Alcohol, which also depresses the central nervous system, would compound the risk further.
Other Medications at Risk
Because wormwood’s enzyme inhibition is broad, affecting both CYP2B6 and CYP3A4, many other drug categories could be affected. CYP2B6 helps process certain antidepressants, HIV medications, and some anesthetics. CYP3A4 is involved in breaking down calcium channel blockers (used for blood pressure), certain cholesterol-lowering statins, immunosuppressants, and many others. Any medication that relies on these enzymes for clearance could accumulate to unsafe levels when wormwood is taken simultaneously.
The irreversible nature of the inhibition means the effect doesn’t simply wear off when you stop taking wormwood. Your body needs time, potentially several days, to produce fresh enzymes and restore normal drug metabolism.
Thujone and Safe Exposure Limits
Thujone is the compound in wormwood most associated with toxicity. The European Medicines Agency sets the maximum daily intake for wormwood preparations at 3 mg of thujone per person, with a hard ceiling of 6 mg per day when accounting for all dietary sources. These limits are based on the threshold for seizures observed in animal studies, with a large safety margin built in.
Wormwood supplements and teas vary enormously in thujone content, making it difficult to know your actual exposure. Products labeled as “thujone-free” may still contain trace amounts. The EMA recommends that wormwood preparations not be used for more than two weeks at the thujone limit, while other health authorities set the maximum duration at four consecutive weeks. Beyond four weeks, the risk of nausea, vomiting, insomnia, restlessness, tremors, and seizures increases substantially.
Who Should Avoid Wormwood Entirely
Certain people face elevated risks regardless of medication use. Wormwood is contraindicated in pregnancy because some of its constituents, particularly sabinyl acetate, have abortifacient properties. This compound can interfere with embryo implantation and is considered one of the most dangerous essential oil constituents for pregnant women.
People with liver disease (including cirrhosis and hepatitis), gallbladder obstruction, or kidney disease should not use wormwood. Given that the liver is the primary site where wormwood inhibits drug-metabolizing enzymes, any preexisting liver impairment would amplify the risks of both direct toxicity and drug interactions. A liver that’s already struggling to process medications will be hit harder by an agent that permanently disables the enzymes doing that work.
Anyone with a seizure disorder faces additional risk, since thujone lowers the seizure threshold. This also means wormwood could reduce the effectiveness of anti-seizure medications, creating a doubly dangerous situation where the supplement both provokes seizures and undermines the drugs meant to prevent them.